Royal DSM N.V. today provides the investment community with comparative quarterly figures for 2008 and Q1 2009.
These comparative figures reflect the reclassification of DSM Energy and Stamicarbon from the Base Chemicals & Materials cluster to discontinued operations as well as the reclassification of DSM's participation in Noordgastransport from Other activities to discontinued operations. These reclassifications follow on the announced intended disposals of these businesses.
The comparative figures can be found in the annex to this press release and can also be downloaded from the Investors section on the DSM corporate website, www.dsm.com.
DSM - the Life Sciences and Materials Sciences Company
Royal DSM N.V. creates innovative products and services in Life Sciences and Materials Sciences that contribute to the quality of life. DSM's products and services are used globally in a wide range of markets and applications, supporting a healthier, more sustainable and more enjoyable way of life. End markets include human and animal nutrition and health, personal care, pharmaceuticals, automotive, coatings and paint, electrical and electronics, life protection and housing. DSM has annual net sales of EUR 9.3 billion and employs some 23,500 people worldwide. The company is headquartered in the Netherlands, with locations on five continents. DSM is listed on Euronext Amsterdam. More information: www.dsm.com
This press release contains forward-looking statements. These statements are based on current expectations, estimates and projections of DSM and information currently available to the company. The statements involve certain risks and uncertainties that are difficult to predict and therefore DSM does not guarantee that its expectations will be realized. Furthermore, DSM has no obligation to update the statements contained in this press release.